SIS
RCKT icon

Sound Income Strategies’s Rocket Pharmaceuticals RCKT Stock Holding History

Sound Income Strategies’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50
Closed -$3K – 1037
2020
Q4 		$3K Hold
50
– – ﹤0.01% 682
2020
Q3 		$1K Hold
50
– – ﹤0.01% 773
2020
Q2 		$1K Hold
50
– – ﹤0.01% 729
2020
Q1 		$1K Buy
+50
New +$990 ﹤0.01% 695

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Sound Income Strategies's RCKT Position: Q1 2021 in Review

Sound Income Strategies sold out of Rocket Pharmaceuticals (RCKT) in Q1 2021, closing a stake of 50 shares — an estimated $3K sold.

Sound Income Strategies first reported a position in RCKT in Q1 2020 and held it in 4 quarters. The position peaked at $3K in Q4 2020. 173 funds tracked by Wall St. Rank hold RCKT as of Q1 2021.

  • Sound Income Strategies reported no remaining Rocket Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Sound Income Strategies sold 50 Rocket Pharmaceuticals shares in Q1 2021, an estimated $3K.
  • Sound Income Strategies first reported a position in Rocket Pharmaceuticals in Q1 2020 and held it in 4 quarters.
  • Sound Income Strategies's Rocket Pharmaceuticals position peaked at $3K in Q4 2020.
  • 173 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q1 2021.

Based on Sound Income Strategies's 13F filing for Q1 2021, filed 14 Apr 2021.